Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1964 1
1966 1
1972 2
1973 2
1974 2
1975 1
1976 1
1979 2
1981 1
1982 1
1986 2
1988 1
1990 1
1992 3
1993 4
1994 12
1996 2
1997 5
1998 3
1999 4
2000 3
2001 13
2002 7
2003 10
2004 5
2005 11
2006 23
2007 31
2008 23
2009 35
2010 38
2011 33
2012 29
2013 29
2014 32
2015 53
2016 38
2017 43
2018 33
2019 22
2020 32
2021 35
2022 20
2023 12
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

592 results

Results by year

Filters applied: . Clear all
Page 1
Radiomics: the bridge between medical imaging and personalized medicine.
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue RTHM, Even AJG, Jochems A, van Wijk Y, Woodruff H, van Soest J, Lustberg T, Roelofs E, van Elmpt W, Dekker A, Mottaghy FM, Wildberger JE, Walsh S. Lambin P, et al. Nat Rev Clin Oncol. 2017 Dec;14(12):749-762. doi: 10.1038/nrclinonc.2017.141. Epub 2017 Oct 4. Nat Rev Clin Oncol. 2017. PMID: 28975929 Review.
Radiomics, the high-throughput mining of quantitative image features from standard-of-care medical imaging that enables data to be extracted and applied within clinical-decision support systems to improve diagnostic, prognostic, and predictive accuracy, is gaining importance in …
Radiomics, the high-throughput mining of quantitative image features from standard-of-care medical imaging that enables data to be extracted …
Structural and functional radiomics for lung cancer.
Wu G, Jochems A, Refaee T, Ibrahim A, Yan C, Sanduleanu S, Woodruff HC, Lambin P. Wu G, et al. Among authors: lambin p. Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3961-3974. doi: 10.1007/s00259-021-05242-1. Epub 2021 Mar 11. Eur J Nucl Med Mol Imaging. 2021. PMID: 33693966 Free PMC article. Review.
INTRODUCTION: Lung cancer ranks second in new cancer cases and first in cancer-related deaths worldwide. ...Radiological images are a powerful non-invasive tool in the screening and diagnosis of early-stage lung cancer, treatment strategy support, prog …
INTRODUCTION: Lung cancer ranks second in new cancer cases and first in cancer-related deaths worldwide. ...Radiologica …
Radiomics: the process and the challenges.
Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D, Goldgof DB, Hall LO, Lambin P, Balagurunathan Y, Gatenby RA, Gillies RJ. Kumar V, et al. Among authors: lambin p. Magn Reson Imaging. 2012 Nov;30(9):1234-48. doi: 10.1016/j.mri.2012.06.010. Epub 2012 Aug 13. Magn Reson Imaging. 2012. PMID: 22898692 Free PMC article. Review.
The focus of this article will be on images of non-small-cell lung cancer....
The focus of this article will be on images of non-small-cell lung cancer....
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.
Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga RJ, Boellaard R, Bogowicz M, Boldrini L, Buvat I, Cook GJR, Davatzikos C, Depeursinge A, Desseroit MC, Dinapoli N, Dinh CV, Echegaray S, El Naqa I, Fedorov AY, Gatta R, Gillies RJ, Goh V, Götz M, Guckenberger M, Ha SM, Hatt M, Isensee F, Lambin P, Leger S, Leijenaar RTH, Lenkowicz J, Lippert F, Losnegård A, Maier-Hein KH, Morin O, Müller H, Napel S, Nioche C, Orlhac F, Pati S, Pfaehler EAG, Rahmim A, Rao AUK, Scherer J, Siddique MM, Sijtsema NM, Socarras Fernandez J, Spezi E, Steenbakkers RJHM, Tanadini-Lang S, Thorwarth D, Troost EGC, Upadhaya T, Valentini V, van Dijk LV, van Griethuysen J, van Velden FHP, Whybra P, Richter C, Löck S. Zwanenburg A, et al. Among authors: lambin p. Radiology. 2020 May;295(2):328-338. doi: 10.1148/radiol.2020191145. Epub 2020 Mar 10. Radiology. 2020. PMID: 32154773 Free PMC article.
In phase II, 15 teams computed values for 1347 derived features using a CT image of a patient with lung cancer and predefined image processing configurations. In both phases, consensus among the teams on the validity of tentative reference values was measured through the f …
In phase II, 15 teams computed values for 1347 derived features using a CT image of a patient with lung cancer and predefined image p …
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.
Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P. Aerts HJ, et al. Among authors: lambin p. Nat Commun. 2014 Jun 3;5:4006. doi: 10.1038/ncomms5006. Nat Commun. 2014. PMID: 24892406 Free PMC article.
Human cancers exhibit strong phenotypic differences that can be visualized noninvasively by medical imaging. ...Here we present a radiomic analysis of 440 features quantifying tumour image intensity, shape and texture, which are extracted from computed tomography da …
Human cancers exhibit strong phenotypic differences that can be visualized noninvasively by medical imaging. ...Here we present a rad …
A novel co-culture assay to assess anti-tumor CD8(+) T cell cytotoxicity via luminescence and multicolor flow cytometry.
Olivo Pimentel V, Yaromina A, Marcus D, Dubois LJ, Lambin P. Olivo Pimentel V, et al. Among authors: lambin p. J Immunol Methods. 2020 Dec;487:112899. doi: 10.1016/j.jim.2020.112899. Epub 2020 Oct 15. J Immunol Methods. 2020. PMID: 33068606 Free article.
T cell immunotherapies have shown great promise in patients with advanced cancer disease, revolutionizing treatment. T cell cytotoxicity is crucial in its efficacy, therefore developing ex vivo methods testing tumor and T cell interactions is pivotal. ...This assay …
T cell immunotherapies have shown great promise in patients with advanced cancer disease, revolutionizing treatment. T cell cytotoxic …
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.
Pettersen EO, Ebbesen P, Gieling RG, Williams KJ, Dubois L, Lambin P, Ward C, Meehan J, Kunkler IH, Langdon SP, Ree AH, Flatmark K, Lyng H, Calzada MJ, Peso LD, Landazuri MO, Görlach A, Flamm H, Kieninger J, Urban G, Weltin A, Singleton DC, Haider S, Buffa FM, Harris AL, Scozzafava A, Supuran CT, Moser I, Jobst G, Busk M, Toustrup K, Overgaard J, Alsner J, Pouyssegur J, Chiche J, Mazure N, Marchiq I, Parks S, Ahmed A, Ashcroft M, Pastorekova S, Cao Y, Rouschop KM, Wouters BG, Koritzinsky M, Mujcic H, Cojocari D. Pettersen EO, et al. Among authors: lambin p. J Enzyme Inhib Med Chem. 2015;30(5):689-721. doi: 10.3109/14756366.2014.966704. Epub 2014 Oct 27. J Enzyme Inhib Med Chem. 2015. PMID: 25347767 Review.
The consequences of this lack may be serious for many patients: Not only is there a negative correlation between the hypoxic fraction in tumours and the outcome of radiotherapy as well as many types of chemotherapy, a correlation has been shown between the hypoxic f …
The consequences of this lack may be serious for many patients: Not only is there a negative correlation between the hypoxic fraction in …
Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review.
Peerlings J, Van De Voorde L, Mitea C, Larue R, Yaromina A, Sandeleanu S, Spiegelberg L, Dubois L, Lambin P, Mottaghy FM. Peerlings J, et al. Among authors: lambin p. Methods. 2017 Nov 1;130:51-62. doi: 10.1016/j.ymeth.2017.07.002. Epub 2017 Jul 10. Methods. 2017. PMID: 28705470 Review.
Promising non-invasive imaging-techniques have been suggested to assess tumor hypoxia and hypoxia-associated molecular responses. However, extensive validation in EC is lacking. ...For personalized hypoxia-guided treatment, safe and reliable makers for …
Promising non-invasive imaging-techniques have been suggested to assess tumor hypoxia and hypoxia-associated molecular …
Epigenetics in radiotherapy: where are we heading?
Smits KM, Melotte V, Niessen HE, Dubois L, Oberije C, Troost EG, Starmans MH, Boutros PC, Vooijs M, van Engeland M, Lambin P. Smits KM, et al. Among authors: lambin p. Radiother Oncol. 2014 May;111(2):168-77. doi: 10.1016/j.radonc.2014.05.001. Epub 2014 May 23. Radiother Oncol. 2014. PMID: 24861629 Review.
Radiotherapy is an important component of anti-cancer treatment. However, not all cancer patients respond to radiotherapy, and with current knowledge clinicians are unable to predict which patients are at high risk of recurrence after radiotherapy
Radiotherapy is an important component of anti-cancer treatment. However, not all cancer patients respond to radioth
Decision Support Systems in Oncology.
Walsh S, de Jong EEC, van Timmeren JE, Ibrahim A, Compter I, Peerlings J, Sanduleanu S, Refaee T, Keek S, Larue RTHM, van Wijk Y, Even AJG, Jochems A, Barakat MS, Leijenaar RTH, Lambin P. Walsh S, et al. Among authors: lambin p. JCO Clin Cancer Inform. 2019 Feb;3:1-9. doi: 10.1200/CCI.18.00001. JCO Clin Cancer Inform. 2019. PMID: 30730766 Free PMC article. Review.
A solution to this challenge is multifactorial decision support systems (DSSs), continuously learning artificial intelligence platforms that integrate all available data-clinical, imaging, biologic, genetic, cost-to produce validated predictive models. DSSs compare the personaliz …
A solution to this challenge is multifactorial decision support systems (DSSs), continuously learning artificial intelligence platforms that …
592 results